Mahboob Vaseem: insider trades.
Mahboob Vaseem reported 8 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($1.3M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- Mahboob Vaseem
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | Officer · Chief Financial Officer | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-07 | Kestra Medical Technologies, Ltd. | S | 500 | $26.33 | 60,609 | Form 4 |
| 2026-08-07 | Kestra Medical Technologies, Ltd. | S | 25,787 | $25.87 | 61,109 | Form 4 |
| 2026-08-04 | Kestra Medical Technologies, Ltd. | S | 3,915 | $25.17 | 86,896 | Form 4 |
| 2026-08-04 | Kestra Medical Technologies, Ltd. | S | 3,080 | $24.06 | 90,811 | Form 4 |
| 2026-08-03 | Kestra Medical Technologies, Ltd. | S | 5,391 | $23.8 | 93,891 | Form 4 |
| 2026-07-31 | Kestra Medical Technologies, Ltd. | S | 8,817 | $22.61 | 99,282 | Form 4 |
| 2026-07-30 | Kestra Medical Technologies, Ltd. | S | 3,980 | $22.75 | 108,099 | Form 4 |
| 2026-07-15 | Kestra Medical Technologies, Ltd. | A | 44,118 | $0 | 112,079 | Form 4 |
Questions
What stock did Mahboob Vaseem buy or sell?
Mahboob Vaseem reported 8 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($1.3M), across 1 company.
Is Mahboob Vaseem the same person as other filers with this name?
This page covers SEC CIK 1655157 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mahboob-vaseem-1655157.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.